Milan, Italy

Sergio Romeo

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Nicox Science Ireland. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sergio Romeo. Retrieved from https://idiyas.com/inventor/sergio-romeo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Sergio Romeo in Ocular Health

Introduction

Sergio Romeo is an accomplished inventor based in Milan, Italy. He has made significant contributions to the field of ocular health through his innovative research and development. His work primarily focuses on the treatment and prevention of glaucoma and ocular hypertension.

Latest Patents

Sergio Romeo holds a patent for "Nitric oxide donating carnosine compounds." This invention relates to nitric oxide donor carnosine derivatives that exhibit great efficacy in reducing elevated intraocular pressure. The patent outlines processes for the preparation of these compounds and their use in the treatment and/or prophylaxis of glaucoma and ocular hypertension. He has 1 patent to his name.

Career Highlights

Sergio Romeo is currently associated with Nicox Science Ireland, where he continues to advance his research in ocular therapeutics. His work has garnered attention for its potential impact on improving patient outcomes in eye health.

Collaborations

Sergio collaborates with notable colleagues, including Nicoletta Almirante and Laura Storoni, who contribute to his research endeavors.

Conclusion

Sergio Romeo's innovative work in developing nitric oxide donating carnosine compounds represents a significant advancement in the treatment of ocular conditions. His contributions are poised to make a lasting impact in the field of ophthalmology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…